Glioblastoma Foundation is pleased to announce the funding of a high impact, FDA-approved technology known as MRI-guided focused ultrasound, specifically for the treatment of glioblastoma, at Weill-Cornell Medical Center.
Glioblastoma Foundation is pleased to announce the funding of a high impact, FDA-approved technology known as MRI-guided focused ultrasound, specifically for the treatment of glioblastoma, at Weill-Cornell Medical Center.